Notably, fusion protein hIMB1636-LDP showed almost the same binding activities to different cancer cells with naked antibody hIMB1636 (Fig. 2a), indicating the connection of apoprotein LDP with the parent anti-Trop2 antibody exerted a minimal adverse effect on the binding affinities of hIMB1636 antibody. This evidence concerns the gene TACSTD2 and cancer.